Delivery Order SPE2DR25D1053-SPE2DR26FT355
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,435.70 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of HYZAAR 50-12.5 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, reflecting the vendor's demonstrated...
- The Defense Logistics Agency (DLA) awarded a $7,941.41 delivery order to AmerisourceBergen Drug Corp for HYZAAR 100-12.5 tablets (90-count units) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical supply requirement supporting federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (a combination antihypertensive medication) in the quantity of 30 units, with a ceiling value of $1,059.30. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is classified as a child award, indicating it derives from a larger contract vehicle. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $15,164.14 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (30 count) under a firm fixed price contract type. This delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of HYZAAR 50-12.5 tablets (30-count units) valued at $2,083.81, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive global...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,464.33 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (90-count units) under a firm fixed price contract. The award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine...
- The Defense Logistics Agency awarded a $2,889.30 delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablet medication (30-count supply), with an ultimate completion date of July 24, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving the federal medical procurement sector, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Hyzaar 50-12.5 tablets in a quantity of 30 units, with a ceiling value of $1,435.30. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $341,650 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561599439 HYZAAR 100-12.5 mg tablets. Under this order, Amerisourcebergen will deliver 90 tablets of the specified hypertension medication to a facility in Conshohocken, Pennsylvania by July 26, 2023 in support of the Defense Logistics Agency's medical supply needs. As a top 10 prime contractor on the Agency's Pharmaceutical Prime Vendor contract,...
- The Defense Logistics Agency awarded a $15,164.14 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Hyzaar 50-12.5 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT355Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of HYZAAR 50-12.5 mg tablets (30-count units) valued at $1,549.20. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in meeting federal procurement requirements through multiple competitive awards across diverse therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/28/25 |